Compilation of Rules and Regulations of the State of Georgia
Department 111 - RULES OF DEPARTMENT OF COMMUNITY HEALTH
Chapter 111-8 - HEALTHCARE FACILITY REGULATION
Subject 111-8-9 - BLOOD LABELING
Rule 111-8-9-.01 - Definitions

(a) "Act" means "The Blood Labeling Act" (O.C.G.A. § 31-24-1et seq.);

(b) "Person" means any individual, blood bank, clinical laboratory, hospital, firm, corporation or any other entity;

(c) "Department" means the Georgia Department of Community Health;

(d) "Board" means the Board of Community Health;

(e) "Clinical Laboratory" means a single facility for the biological, microbiological, serological, immunological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body, for the diagnosis of, recommendation of treatment of, or for the purpose of providing for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of the health of, man; the term "clinical laboratory" shall include blood banks which provide through their ownership or operation a system for the collection, processing, or storage of human blood and its component parts as well as tissue banks which store human or animal tissues designed to be used for medical purposes in human beings.

(f) "Director" means a person who is responsible for the administration of the technical and scientific operation of a clinical laboratory, including supervision of procedures for testing and the reporting of results;

(g) "Blood" means whole human blood, packed red blood cells, blood platelets, concentrated leukocytes, and blood plasma. It does not include blood derivatives manufactured or processed for industrial use.

(h) "Donation" means any transaction involving the person from whom blood is withdrawn, whether he presents himself for the withdrawal of blood on his own initiative or on the initiative of another person, in which he receives no consideration other than credit through blood assurance programs or other intangible benefits.

(i) "Purchase" means any transaction involving the person from whom blood is withdrawn, whether he presents himself for the withdrawal of blood on his own initiative or on the initiative of another person, in which he receives a monetary consideration in any form. Time off from work granted by an employer for the purpose of giving blood shall not be considered a direct monetary consideration.

(j) "Industrial use" means a use of blood in which the blood is modified by physical or chemical means to produce derivatives for therapeutic or pharmaceutic biologicals and laboratory reagents or controls.

(k) "Transfusion" means a use of blood in which the blood is administered to a human being for treatment of sickness or injury.